Use of fetal tissue in vaccine development

Use of Fetal Tissue in Vaccine Development

The use of fetal tissue in vaccine development is a practice that has been instrumental in the creation of several important vaccines, including those for rubella, hepatitis A, and chickenpox. This practice involves the use of cell lines derived from aborted fetal tissue, which are used as a medium for growing viruses that are then used in vaccines.

History[edit | edit source]

The use of fetal tissue in vaccine development dates back to the mid-20th century. In the 1960s, scientists at the Wistar Institute developed a cell line known as WI-38, which was derived from the lung tissue of an aborted fetus. This cell line was used in the development of the rubella vaccine, which has since prevented countless cases of congenital rubella syndrome worldwide.

Process[edit | edit source]

The process of using fetal tissue in vaccine development begins with the creation of a cell line. This involves taking a small sample of tissue, often from a lung or kidney, and treating it with enzymes to break it down into individual cells. These cells are then cultured in a laboratory, where they multiply and form a stable line of cells that can be used for research.

Once a cell line has been established, it can be used as a medium for growing viruses. The viruses are introduced into the cells, where they reproduce. The virus-infected cells are then harvested and used to create vaccines.

It's important to note that the cell lines used in vaccine development are not the same as the original fetal tissue. They are copies of the original cells, which have been multiplied many times over in the lab. The original fetal tissue used to create these cell lines was obtained decades ago, and no new fetal tissue is needed to produce vaccines.

Ethical Considerations[edit | edit source]

The use of fetal tissue in vaccine development has been the subject of ethical debate. Some people object to the practice on moral or religious grounds, while others argue that the benefits of vaccines outweigh any ethical concerns. It's important to note that the World Health Organization and other major health organizations support the use of these vaccines, citing their crucial role in preventing serious diseases.

Conclusion[edit | edit source]

The use of fetal tissue in vaccine development has played a crucial role in the fight against many serious diseases. While the practice has been the subject of ethical debate, the consensus among health organizations is that the benefits of these vaccines outweigh any potential ethical concerns.